Fri, Dec 26, 2014, 4:33 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Natus Medical Inc. Message Board

soooverylucky 6 posts  |  Last Activity: Dec 24, 2014 8:18 AM Member since: Apr 4, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • http://news.morningstar.com/articlenet/article.aspx?id=678618&SR=Yahoo

    Merry Christmas.

  • soooverylucky by soooverylucky Dec 2, 2014 8:03 AM Flag

    A little odd, in that it's outside the normal scope of Ebix offerings. But it signals an aggressiveness that I like. Plus, they say it will be immediately acretive to earnings.

  • soooverylucky soooverylucky Dec 1, 2014 6:47 PM Flag

    Only stock in my portfolio that was green today. So that's something....

  • Reply to

    2 new board members

    by xeloris99 Dec 1, 2014 8:16 AM
    soooverylucky soooverylucky Dec 1, 2014 10:16 AM Flag

    This is all good. I didn't think Robin would be this flexible, but chances are he is sick of seeing the stock price underperform, and is perhaps grasping at a lifeline.

  • soooverylucky by soooverylucky Oct 22, 2014 7:52 AM Flag

    Not sure if it will increase the stock price all that much, but it certainly justifies it staying at present levels. Bad news for the shorts on this board...

    The Company reported non-GAAP net income of $10.6 million for the third quarter ended September 30, 2014, an increase of 16.5% over the prior year of $9.1 million. Non-GAAP earnings per diluted share increased to $0.33 for the third quarter of 2014 from $0.30 per diluted share reported for the third quarter of 2013.

    For the nine months ended September 30, 2014, the Company reported revenue of $261.8 million, an increase of 3.3% compared to $253.5 million reported for the same period in 2013. GAAP net income was $21.8 million, or $0.67 per diluted share, compared with net income of $13.7 million, or $0.45 per diluted share in the third quarter of 2013.

    The Company reported non-GAAP net income of $27.8 million for the nine months ended September 30, 2014, an increase of 39.7% over the prior year of $19.9 million. Non-GAAP earnings per diluted share increased to $0.86 for the third quarter 2014 from $0.65 per diluted share reported for the same period in the previous year.

    Cash and cash equivalents increased by $1.8 million to $57.8 million during the quarter and total debt was reduced by $8.4 million to $8.0 million. The Company also repurchased $2.5 million of company stock during the third quarter. Cash flow from operations was approximately $16 million for the third quarter.

    "I am very pleased with our third quarter results as we achieved record revenues and earnings. Both revenue and earnings exceeded the top end of guidance. I am most satisfied with our 63% gross profit margin as well as recording over 5% organic revenue growth. Consistent organic revenue growth and improving margins have been major goals for Natus in 2014 and our results demonstrate significant progress to the achievement of these goals," said Jim Hawkins, President and Chief Executive Officer of the Company.

    "I remain excited about our Peloton Hearing Screening Service business as we added 17 hospitals during the quarter and we ended the quarter with 39 hospitals under contact. Including contracts already signed during October, we have exceeded our 2014 goal of 40 hospitals under contract by the end of the year," Mr. Hawkins continued.

  • Great to see them up over 7% in this lousy market environment today.

    Sentiment: Hold

BABY
36.55+0.10(+0.27%)4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.